HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jian Ding Selected Research

Integrins

8/2015Integrin α4β7 Expression Increases HIV Susceptibility in Activated Cervical CD4+ T Cells by an HIV Attachment-Independent Mechanism.
2/2008Salvicine inactivates beta 1 integrin and inhibits adhesion of MDA-MB-435 cells to fibronectin via reactive oxygen species signaling.
9/2007Philinopside E, a new sulfated saponin from sea cucumber, blocks the interaction between kinase insert domain-containing receptor (KDR) and alphavbeta3 integrin via binding to the extracellular domain of KDR.
10/2006[The basement membrane and metastasis].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jian Ding Research Topics

Disease

242Neoplasms (Cancer)
06/2024 - 12/2002
46Breast Neoplasms (Breast Cancer)
02/2024 - 07/2004
38Neoplasm Metastasis (Metastasis)
06/2024 - 07/2004
20Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2024 - 09/2006
19Leukemia
01/2022 - 12/2002
16Carcinoma (Carcinomatosis)
08/2016 - 07/2003
12Carcinogenesis
06/2024 - 08/2005
12Necrosis
03/2024 - 09/2009
12Infections
01/2022 - 03/2002
11Stomach Neoplasms (Stomach Cancer)
05/2023 - 01/2008
11Hepatocellular Carcinoma (Hepatoma)
01/2021 - 07/2004
10Lung Neoplasms (Lung Cancer)
12/2023 - 06/2005
10Parkinson Disease (Parkinson's Disease)
05/2022 - 08/2015
9Ovarian Neoplasms (Ovarian Cancer)
12/2023 - 08/2004
9Inflammation (Inflammations)
01/2023 - 11/2011
9Colonic Neoplasms (Colon Cancer)
04/2021 - 04/2005
9Hypoxia (Hypoxemia)
01/2020 - 12/2004
8Ischemia
03/2024 - 05/2015
8Body Weight (Weight, Body)
01/2023 - 10/2011
7Fibrosis (Cirrhosis)
01/2024 - 11/2009
7Brain Ischemia (Cerebral Ischemia)
05/2023 - 02/2014
7Non-alcoholic Fatty Liver Disease
03/2023 - 01/2019
7Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 04/2005
6Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
10/2023 - 12/2019
6Edema (Dropsy)
01/2021 - 01/2018
6HIV Infections (HIV Infection)
01/2018 - 03/2010
5Esophageal Squamous Cell Carcinoma
12/2023 - 10/2019
5Adenocarcinoma
11/2023 - 06/2005
5Wounds and Injuries (Trauma)
01/2021 - 02/2008
5Acquired Immunodeficiency Syndrome (AIDS)
01/2018 - 08/2004
5Ataxia Telangiectasia (Louis Bar Syndrome)
01/2012 - 02/2007
4Bites and Stings (Sting)
03/2024 - 12/2022
4Ischemic Stroke
11/2023 - 03/2020
4Squamous Cell Carcinoma of Head and Neck
09/2023 - 01/2021
4B-Cell Lymphoma (Lymphoma, B Cell)
01/2022 - 12/2018
4Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 11/2017
4Hypersensitivity (Allergy)
01/2020 - 05/2005
4Adenocarcinoma of Lung
01/2018 - 07/2004

Drug/Important Bio-Agent (IBA)

40Proteins (Proteins, Gene)FDA Link
06/2024 - 12/2004
33Phosphotransferases (Kinase)IBA
01/2022 - 10/2005
24Biomarkers (Surrogate Marker)IBA
03/2023 - 10/2005
15DNA (Deoxyribonucleic Acid)IBA
01/2024 - 10/2005
13Tyrosine (L-Tyrosine)FDA Link
04/2024 - 04/2005
13salvicineIBA
09/2008 - 12/2002
11CytokinesIBA
04/2024 - 01/2005
10ErbB Receptors (EGF Receptor)IBA
01/2023 - 12/2008
10MicroRNAs (MicroRNA)IBA
10/2022 - 01/2013
10Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2018 - 12/2004
9Long Noncoding RNAIBA
06/2024 - 01/2014
9EnzymesIBA
03/2024 - 08/2015
9Messenger RNA (mRNA)IBA
01/2024 - 10/2004
9heparanaseIBA
08/2018 - 10/2005
8Therapeutic UsesIBA
01/2023 - 12/2005
7RNA (Ribonucleic Acid)IBA
06/2024 - 09/2014
7Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
11/2023 - 01/2017
7IronIBA
10/2023 - 07/2008
7Small Interfering RNA (siRNA)IBA
02/2020 - 04/2007
7Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
02/2017 - 01/2003
7trioctyl phosphine oxide (TOPO)IBA
12/2014 - 02/2007
6Gefitinib (Iressa)FDA Link
01/2022 - 11/2015
6Type II DNA Topoisomerases (Topoisomerase II)IBA
04/2015 - 08/2003
5Reactive Oxygen Species (Oxygen Radicals)IBA
03/2024 - 07/2008
5CYH33IBA
12/2023 - 10/2018
5Transcription Factors (Transcription Factor)IBA
10/2023 - 10/2010
5osimertinibIBA
01/2023 - 01/2019
5Tyrosine Kinase InhibitorsIBA
01/2023 - 06/2005
5Cisplatin (Platino)FDA LinkGeneric
01/2021 - 07/2003
5Antineoplastic Agents (Antineoplastics)IBA
03/2018 - 10/2004
5Doxorubicin (Adriamycin)FDA LinkGeneric
01/2018 - 07/2004
5Epidermal Growth Factor (EGF)IBA
12/2017 - 08/2004
5TubulinIBA
07/2014 - 04/2006
5OligosaccharidesIBA
06/2014 - 02/2005
5oligomannurarate sulfateIBA
06/2014 - 09/2006
5TOR Serine-Threonine KinasesIBA
01/2014 - 01/2009
5Fibronectins (Fibronectin)IBA
11/2009 - 05/2005
5Focal Adhesion Protein-Tyrosine KinasesIBA
11/2008 - 04/2005
4InflammasomesIBA
03/2024 - 06/2017
4Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
12/2023 - 11/2014
4Fluorouracil (Carac)FDA LinkGeneric
09/2023 - 06/2005
4Interleukin-6 (Interleukin 6)IBA
02/2023 - 01/2019
4Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2023 - 01/2017
4AntigensIBA
01/2023 - 02/2005
4Glucose (Dextrose)FDA LinkGeneric
01/2023 - 10/2015
4Amino AcidsFDA Link
01/2023 - 10/2019
4Histones (Histone)IBA
01/2023 - 01/2013
4AntioxidantsIBA
04/2022 - 08/2015
4LipidsIBA
01/2022 - 10/2015
4PlasticsIBA
01/2021 - 01/2017
4Angiogenesis InhibitorsIBA
01/2021 - 04/2006
4Hematoxylin (Haematoxylon)IBA
01/2021 - 07/2011
4Sirolimus (Rapamycin)FDA Link
02/2020 - 09/2010
4Adenosine Triphosphate (ATP)IBA
01/2019 - 11/2006
4Matrix Metalloproteinases (MMPs)IBA
01/2019 - 11/2004

Therapy/Procedure

102Therapeutics
06/2024 - 08/2003
16Drug Therapy (Chemotherapy)
01/2024 - 01/2006
11Oral Administration
02/2022 - 01/2014
10Immunotherapy
06/2024 - 01/2018
9Electroacupuncture
05/2023 - 02/2014
5Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2024 - 05/2007
4Perforator Flap
03/2024 - 05/2017